Skip to main content
University of California San Francisco
Give to UCSF
Anesthesia
Labs & Groups
Recombinant Antibody Core Facility
Recombinant Antibody Core Facility
Search the Site
Lab Home
People
Publications
Contact Us
Search
Breadcrumb
Home
/
Labs and Groups
/
Recombinant Antibody Core Facility
/
Publications
Publications
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC
Clinical cancer research : an official journal of the American Association for Cancer Research
.
Apr 1, 2002
The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies.
Visintin M, Settanni G, Maritan A, Graziosi S, Marks JD, Cattaneo A
Journal of molecular biology
.
Mar 15, 2002
Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.
Amersdorfer P, Wong C, Smith T, Chen S, Deshpande S, Sheridan R, Marks JD
Vaccine
.
Feb 22, 2002
Phage-display antibody detection of Chlamydia trachomatis-associated antigens.
Lindquist EA, Marks JD, Kleba BJ, Stephens RS
Microbiology (Reading, England)
.
Feb 1, 2002
Towards proteome-wide production of monoclonal antibody by phage display.
Liu B, Huang L, Sihlbom C, Burlingame A, Marks JD
Journal of molecular biology
.
Feb 1, 2002
Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.
Mullaney BP, Pallavicini MG, Marks JD
Infection and immunity
.
Oct 1, 2001
Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
Li X, Stuckert P, Bosch I, Marks JD, Marasco WA
Cancer gene therapy
.
Aug 1, 2001
Tumor targeting using anti-her2 immunoliposomes.
Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC
Journal of controlled release : official journal of the Controlled Release Society
.
Jul 6, 2001
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM
Cancer research
.
Jun 15, 2001
Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity.
McCall AM, Shahied L, Amoroso AR, Horak EM, Simmons HH, Nielson U, Adams GP, Schier R, Marks JD, Weiner LM
Journal of immunology (Baltimore, Md. : 1950)
.
May 15, 2001
Load More